The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a systematic review and economic model.

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a systematic review and economic model.

Bibliographic Details
Main Authors: M Bond, G Rogers, J Peters, R Anderson, M Hoyle, A Miners, T Moxham, S Davis, P Thokala, A Wailoo, M Jeffreys, C Hyde
Format: Article
Language:English
Published: NIHR Journals Library 2012-04-01
Series:Health Technology Assessment
Online Access:https://doi.org/10.3310/hta16210

Internet

https://doi.org/10.3310/hta16210

Similar Items